| 000 | 01598 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515102652.0 | ||
| 264 | 0 | _c20080116 | |
| 008 | 200801s 0 0 rus d | ||
| 022 | _a0507-3758 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGershanovich, M L | |
| 245 | 0 | 0 |
_a[Dicarbamin--an effective protector of myelodepression in combined treatment for Hodgkin's disease]. _h[electronic resource] |
| 260 |
_bVoprosy onkologii _c2007 |
||
| 300 |
_a589-95 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBleomycin _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aCaproates |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aDacarbazine _xadministration & dosage |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocytes _xdrug effects |
| 650 | 0 | 4 |
_aHodgkin Disease _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aProtective Agents _xpharmacology |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aFilatova, L V | |
| 773 | 0 |
_tVoprosy onkologii _gvol. 53 _gno. 5 _gp. 589-95 |
|
| 999 |
_c17665754 _d17665754 |
||